Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs in hematological malignancies
Epigenetic drugs are emerging as a powerful therapeutic option for cancer treatment. Here, the authors synthesized selective chemical probes that simultaneously inhibit the G9a and DNMTs methyltransferase activity and demonstrate their anti-tumour activity usingin vitro and in vivomodels of haematol...
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2017-05-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/ncomms15424 |